Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lennart Åström"'
Autor:
Silvia Johansson, Lennart Åström, Fredrik Sandin, Ulf Isacsson, Anders Montelius, Ingela Turesson
Publikováno v:
Prostate Cancer, Vol 2012 (2012)
Proton boost of 20 Gy in daily 5 Gy fractions followed by external beam radiotherapy (EBRT) of 50 Gy in daily 2 Gy fractions were given to 278 patients with prostate cancer with T1b to T4N0M0 disease. Fifty-three percent of the patients received neoa
Externí odkaz:
https://doaj.org/article/5509aa9d815e4732a0f5342e3c1c5d41
Autor:
Axel S, Merseburger, Gerhardt, Attard, Lennart, Åström, Vsevolod B, Matveev, Sergio, Bracarda, Adil, Esen, Susan, Feyerabend, Elżbieta, Senkus, Marta, López-Brea Piqueras, Gunther, Boysen, Georgia, Gourgioti, Karla, Martins, Simon, Chowdhury
Although androgen deprivation therapy is typically given long-term for men with metastatic prostate cancer, second-generation hormone therapies are generally discontinued before the subsequent line of treatment. We aimed to evaluate the efficacy of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262d4c30d3cfb322204d9f74be650bf1
https://avesis.deu.edu.tr/publication/details/1fc3be0d-df24-4a2f-865d-a39d50aae72c/oai
https://avesis.deu.edu.tr/publication/details/1fc3be0d-df24-4a2f-865d-a39d50aae72c/oai
Publikováno v:
Radiotherapy and Oncology. 129:561-566
PSA kinetics after curative radiotherapy for prostate cancer is an important part of the posttreatment evaluation. We analysed PSA bounce occurrence after combined high dose rate brachytherapy (HDR-BT) and external radiotherapy (ERT).We analysed 623
Publikováno v:
Radiotherapy and Oncology. 127:81-87
High-dose-rate brachytherapy (HDR-BT) has optimal prerequisites in radiotherapy of prostate cancer (PC) with a conformal dose distribution and high doses per fraction giving a biological dose escalation. We report the outcome after HDR-BT and externa
Autor:
Lars Franzén, Lennart Åström, Teppo Huttunen, Marie Hjälm-Eriksson, Camilla Thellenberg-Karlsson, Mihalj Zeke, Pirkko-Liisa Kellokumpu-Lehtinen, Claes Ginman, Markku J Leskinen, Ann-Sofie Fransson
Publikováno v:
European urology. 76(6)
Background Docetaxel combined with androgen deprivation therapy (ADT) has improved patient survival for advanced prostate cancer (PCa). Objective This randomised trial aimed to evaluate whether six courses of docetaxel improved biochemical disease–
Autor:
Ann-Sofie Fransson, Pirkko-Liisa Kellokumpu-Lehtinen, Lars Franzén, Claes Ginman, Teppo Huttunen, Markku J Leskinen, Camilla Thellenberg-Karlsson, Marie Hjälm-Eriksson, Lennart Åström
Publikováno v:
Journal of Clinical Oncology. 38:313-313
313 Background: Six docetaxel cycles did not improve PSA relapse free survival as an adjuvant treatment after radical RT (Kellokumpu-Lehtinen EURURO-8532). Here we report SPCG-13 trials QoL results. Methods: A total of 376 PC patients (T2 with Gleaso
Autor:
Teppo Huttunen, Camilla Thellenberg-Karlsson, Widmark Anders, Marie Hjälm-Eriksson, Lennart Åström, Sten Nilsson, Timo Marttila, Pirkko-Liisa Kellokumpu-Lehtinen, Claes Ginman
Publikováno v:
Journal of Clinical Oncology. 36:5000-5000
5000Background: Docetaxel combined with androgen deprivation therapy (ADT) has improved survival in advanced prostate cancer (PCa). This randomized trial evaluates if six courses of docetaxel impro...
Publikováno v:
Journal of Physics: Conference Series. 1021:012068
Publikováno v:
Acta Medica Scandinavica. 203:231-235
This report concerns two patients, a 43-year-old woman and a 53-year-old man, who developed clinical as well as laboratory signs of permanent gonodal and thyroid failure following an acute intracranial infection--in the woman a meningoencephalitis of
Autor:
Anders Montelius, Lennart Åström, Ingela Turesson, Fredrik Sandin, Ulf Isacsson, Silvia Johansson
Publikováno v:
Radiotherapy and Oncology. 106